Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can keyhole spine fusion ease chronic back pain?

NCT ID NCT06545032

Symptom relief Sponsor: Sohag University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 17, 2026 · Last updated Sep 18, 2026 · Updated 1 time

Summary

Researchers at Sohag University are studying a minimally invasive spine surgery called MI-TLIF for people with degenerative lumbar and lumbosacral spine diseases. The trial enrolls about 30 adults with conditions such as degenerative spondylolisthesis, disc herniation, or recurrent disc herniation. The team compares pain levels before and after surgery using a visual analog scale to see if the procedure reduces pain and improves surgical outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
minimally invasive transforaminal lumbar interbody fusion (MI-TLIF) surgery
What this could lead to
If successful, this could offer a less invasive surgical option that reduces pain and speeds recovery for people with degenerative spine conditions.
What could go wrong
This is a small study at a single center, so results may not apply broadly. Surgery carries risks such as infection, nerve damage, or failure to relieve pain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Sep 2024

Finished

Sep 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Degenerative spondylolisthesis. * Degenerative unilateral disc herniations. * Recurrent disc herniation. Exclusion Criteria: * Spondylolisthesis Grade III or IV. * Degenerative scoliosis . * Traumatic fracture spine. * Infections. * Neoplasms. * Debilitated patients . * Coagulation dysfunction. * Severe osteoporosis.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Degenerative spine diseases are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

spondylolisthesis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Degenerative spine diseases

Contacts and locations

Locations

  • Sohag University

    Sohag, Sohag Governorate, 82511, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.